Brief: Panbela Therapeutics Reports Q4 Loss Per Share $0.09 (March 25)
26/03/2021 12:59
March 26 (Reuters) - Panbela Therapeutics Inc PBLA.O :
* PANBELA PROVIDES BUSINESS UPDATE AND REPORTS Q4 AND FY
2020
FINANCIAL RESULTS
* Q4 LOSS PER SHARE $0.09
Source text for Eikon: ID:nGNXbNCRtL
Further company coverage: PBLA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Panbela Therapeutics
See all newsBrief: Panbela Therapeutics Announces Third Independent Safety Review Of Phase 3 Aspire Clinical Trial DSMB Recommended Continuation With No Trial Modification
Brief: Nasdaq Notifies Panbela Therapeutics Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard
Brief: Panbela Announces Pricing of Approximately $9 Mln Public Offering
U.S. STOCKS ON THE MOVE-Fisker, Best Buy, NuStar Energy
Brief: Panbela Therapeutics Announces Exercise Of Warrants And Issuance Of New Warrants